These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 35211219)

  • 1. Updates on Baroreflex Activation Therapy and Vagus Nerve Stimulation for Treatment of Heart Failure With Reduced Ejection Fraction.
    Babar N; Giedrimiene D
    Cardiol Res; 2022 Feb; 13(1):11-17. PubMed ID: 35211219
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Baroreflex activation therapy for the treatment of heart failure with a reduced ejection fraction: safety and efficacy in patients with and without cardiac resynchronization therapy.
    Zile MR; Abraham WT; Weaver FA; Butter C; Ducharme A; Halbach M; Klug D; Lovett EG; Müller-Ehmsen J; Schafer JE; Senni M; Swarup V; Wachter R; Little WC
    Eur J Heart Fail; 2015 Oct; 17(10):1066-74. PubMed ID: 26011593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-pharmacologic autonomic neuromodulation for treatment of heart failure: A systematic review and meta-analysis of randomized controlled trials.
    Ahmed M; Nudy M; Bussa R; Weigel F; Naccarelli G; Maheshwari A
    Trends Cardiovasc Med; 2024 Feb; 34(2):101-107. PubMed ID: 36202286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Baroreflex Activation Therapy in Patients With Heart Failure With Reduced Ejection Fraction.
    Zile MR; Lindenfeld J; Weaver FA; Zannad F; Galle E; Rogers T; Abraham WT
    J Am Coll Cardiol; 2020 Jul; 76(1):1-13. PubMed ID: 32616150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of symptomatic and functional responses to vagus nerve stimulation in ANTHEM-HF, INOVATE-HF, and NECTAR-HF.
    Anand IS; Konstam MA; Klein HU; Mann DL; Ardell JL; Gregory DD; Massaro JM; Libbus I; DiCarlo LA; Udelson JJE; Butler J; Parker JD; Teerlink JR
    ESC Heart Fail; 2020 Feb; 7(1):75-83. PubMed ID: 31984682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implantation of a vagus nerve stimulator for patients with heart failure with reduced ejection fraction: An educational video.
    Al Rameni D; Akay M; Jumean M; Al Rameeni A; Kar B; Gregoric ID
    JTCVS Tech; 2022 Aug; 14():96-98. PubMed ID: 35967202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and efficacy of baroreflex activation therapy for heart failure with reduced ejection fraction: a rapid systematic review.
    Schmidt R; Rodrigues CG; Schmidt KH; Irigoyen MCC
    ESC Heart Fail; 2020 Feb; 7(1):3-14. PubMed ID: 31965746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autonomic regulation therapy via left or right cervical vagus nerve stimulation in patients with chronic heart failure: results of the ANTHEM-HF trial.
    Premchand RK; Sharma K; Mittal S; Monteiro R; Dixit S; Libbus I; DiCarlo LA; Ardell JL; Rector TS; Amurthur B; KenKnight BH; Anand IS
    J Card Fail; 2014 Nov; 20(11):808-16. PubMed ID: 25187002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term chronic baroreflex activation: persistent efficacy in patients with heart failure and reduced ejection fraction.
    Gronda E; Seravalle G; Trevano FQ; Costantino G; Casini A; Alsheraei A; Lovett EG; Vanoli E; Mancia G; Grassi G
    J Hypertens; 2015 Aug; 33(8):1704-8. PubMed ID: 26132760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Baroreflex activation therapy for the treatment of heart failure with reduced ejection fraction in patients with and without coronary artery disease.
    Halbach M; Abraham WT; Butter C; Ducharme A; Klug D; Little WC; Reuter H; Schafer JE; Senni M; Swarup V; Wachter R; Weaver FA; Wilks SJ; Zile MR; Müller-Ehmsen J
    Int J Cardiol; 2018 Sep; 266():187-192. PubMed ID: 29705650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surgical Experience and Long-term Results of Baroreflex Activation Therapy for Heart Failure With Reduced Ejection Fraction.
    Weaver FA; Abraham WT; Little WC; Butter C; Ducharme A; Halbach M; Klug D; Lovett EG; Madershahian N; Müller-Ehmsen J; Schafer JE; Senni M; Swarup V; Wachter R; Zile MR
    Semin Thorac Cardiovasc Surg; 2016 Summer; 28(2):320-328. PubMed ID: 28043438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advances in Our Clinical Understanding of Autonomic Regulation Therapy Using Vagal Nerve Stimulation in Patients Living With Heart Failure.
    Konstam MA; Mann DL; Udelson JJE; Ardell JL; De Ferrari GM; Cowie MR; Klein HU; Gregory DD; Massaro JM; Libbus I; DiCarlo LA; Butler J; Parker JD; Teerlink JR
    Front Physiol; 2022; 13():857538. PubMed ID: 35530511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Baroreflex activation therapy. A novel interventional approach to treat heart failure with reduced ejection fraction].
    Halbach M; Fritz T; Madershahian N; Pfister R; Reuter H
    Herz; 2015 Nov; 40(7):959-65. PubMed ID: 26525523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Restoration of normal sympathetic neural function in heart failure following baroreflex activation therapy: final 43-month study report.
    Dell'Oro R; Gronda E; Seravalle G; Costantino G; Alberti L; Baronio B; Staine T; Vanoli E; Mancia G; Grassi G
    J Hypertens; 2017 Dec; 35(12):2532-2536. PubMed ID: 28816745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Striking improvement in a case of reduced ejection fraction heart failure with baroreflex activation therapy.
    Gronda E; Brambilla G; Lovett EG; Costantino G; Georgakpoulos D; Vanoli E
    J Cardiol Cases; 2014 Jul; 10(1):4-6. PubMed ID: 30534210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic vagus nerve stimulation improves autonomic control and attenuates systemic inflammation and heart failure progression in a canine high-rate pacing model.
    Zhang Y; Popovic ZB; Bibevski S; Fakhry I; Sica DA; Van Wagoner DR; Mazgalev TN
    Circ Heart Fail; 2009 Nov; 2(6):692-9. PubMed ID: 19919995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Baroreflex activation therapy: a new treatment option for heart failure with reduced ejection fraction.
    Halbach M; Hickethier T; Madershahian N; Müller-Ehmsen J
    Expert Rev Cardiovasc Ther; 2014 Dec; 12(12):1465-9. PubMed ID: 25382103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rationale and study design of the NEuroCardiac TherApy foR Heart Failure Study: NECTAR-HF.
    De Ferrari GM; Tuinenburg AE; Ruble S; Brugada J; Klein H; Butter C; Wright DJ; Schubert B; Solomon S; Meyer S; Stein K; Ramuzat A; Zannad F
    Eur J Heart Fail; 2014 Jun; 16(6):692-9. PubMed ID: 24846173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiac Contractility Modulation and Baroreflex Activation Therapy in Heart Failure Patients.
    Mann JA; Abraham WT
    Curr Heart Fail Rep; 2019 Feb; 16(1):38-46. PubMed ID: 30762177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuromodulation devices for heart failure
    Dusi V; Angelini F; Zile MR; De Ferrari GM
    Eur Heart J Suppl; 2022 Sep; 24(Suppl E):E12-E27. PubMed ID: 35991619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.